Statins may improve circulation in the retinaMay 09, 2006The cholesterol-lowering medications known as statins may improve circulation in the eye, potentially reducing the risk of certain eye diseases, according to a study in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Statins have previously been shown to relax blood vessels and reduce the risk of stroke and heart disease, even in patients without high cholesterol, according to background information in the article. The effect of statins on circulation in the retina has not been studied previously, but researchers have found that long-term use of statins may reduce the risk of glaucoma, age-related macular degeneration and other eye conditions. These diseases are thought to be associated with problems in circulation in the eye. Taiji Nagaoka, M.D., Ph.D., Asahikawa Medical College, Japan, and colleagues randomly assigned 12 healthy men (average age 21 years) to receive either a 20-milligram dose of simvastatin or an identical placebo each morning for seven days. The researchers measured blood flow in the men's retinal arteries and veins at the beginning of the study, 90 minutes after administering the drug the first day and at the end of seven days. They also assessed the participants' blood intraocular pressure, or the pressure within the eyeball. The seven-day regimen was repeated again 28 days after the first phase of the study ended. Among patients taking statins, intraocular pressure was reduced 90 minutes after taking the medication and at the seven-day mark. Blood velocity (speed) and blood flow were significantly increased in patients who had taken statins for seven days, although the size of the blood vessels did not change. These findings may have implications for several eye diseases, the authors write. For instance, diabetic retinopathy, which occurs when poorly controlled diabetes damages the eyes and which can eventually lead to blindness, was recently linked to reduced blood flow in the eye. "Although the findings in the present study are obtained from healthy men whose physiological response to simvastatin may be different from that of patients with diabetes, the increased retinal blood flow associated with treatment with simvastatin may be a potential therapy for diabetic retinopathy," the authors write. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Statins Current Events and Statins News Articles Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Researchers mobilizing global resources to test new treatments for severe H1N1 infection An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Statins show dramatic drug and cell dependent effects in the brain Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. Cholesterol-lowering medicines may be effective against cancer Statins lower cholesterol by blocking certain enzymes involved in our metabolism. Adding ezetimibe to atorvastatin improves lipid control Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone. Use of statins favors the wealthy, creating new social disparities in cholesterol Since the introduction of statins to treat high cholesterol, the decline in lipid levels experienced by the wealthy has been double that experienced by the poor. Women with Atrial Fibrillation Are at Significantly Higher Risk of Stroke and Death Compared to Men and Receive Less Attention Even though the incidence of atrial fibrillation is higher in men than women, a review of past studies and medical literature completed by cardiac experts at Rush University Medical Center shows that women are more likely than men to experience symptomatic attacks, a higher frequency of recurrences, and significantly higher heart rates during atrial fibrillation, which increases the risk of stroke. Pre-hospital organization: The first links in the chain of survival for heart attack patients Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%. Fatostatin' is a turnoff for fat genes A small molecule earlier found to have both anti-fat and anti-cancer abilities works as a literal turnoff for fat-making genes, according to a new report in the August 28th issue of the journal Chemistry and Biology, a Cell Press journal. More Statins Current Events and Statins News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||